Skip to main content
. 2014 Oct 4;16(5):460. doi: 10.1186/s13075-014-0460-x

Figure 2.

Figure 2

Correlation between the values of Disease Activity Score in 28 joints and serum sclerostin concentration before treatment and during tumour necrosis factor α inhibitor treatment. Disease Activity Score in 28 joints (DAS28) =3.332 + (0.104 × sclerostin) (r =0.32, P =0.002). Filled circles: baseline values; open triangles: 1 year of treatment; open squares: 2 years of treatment.